269
Views
5
CrossRef citations to date
0
Altmetric
CLINICAL

Amyotrophic lateral sclerosis onset after prolonged treatment with a VEGF receptors inhibitor

, , , , , , , , & show all
Pages 129-130 | Received 06 Jun 2014, Accepted 20 Sep 2014, Published online: 22 Oct 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Elena V. Lysogorskaia, Nataliya Yu Abramycheva, Mariya N. Zakharova, Mariya S. Stepanova, Anna A. Moroz, Alexey V. Rossokhin & Sergey N. Illarioshkin. (2016) Genetic studies of Russian patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:1-2, pages 135-141.
Read now

Articles from other publishers (4)

Rafael Gonzalo-Gobernado, Laura Moreno-Martínez, Paz González, Xose Manuel Dopazo, Ana Cristina Calvo, Isabel Pidal-Ladrón de Guevara, Elisa Seisdedos, Rodrigo Díaz-Muñoz, Britt Mellström, Rosario Osta & José Ramón Naranjo. (2023) Repaglinide Induces ATF6 Processing and Neuroprotection in Transgenic SOD1G93A Mice. International Journal of Molecular Sciences 24:21, pages 15783.
Crossref
Philip Van Damme, Petra Tilkin, Katarina Jansson Mercer, Joke Terryn, Ann D’Hondt, Nina Herne, Thomas Tousseyn, Kristl G Claeys, Dietmar R Thal, Olof Zachrisson, Per Almqvist, Bart Nuttin, Markus Jerling, Folke Bernadotte, Anders Haegerstrand & Wim Robberecht. (2020) Intracerebroventricular delivery of vascular endothelial growth factor in patients with amyotrophic lateral sclerosis, a phase I study. Brain Communications 2:2.
Crossref
Luca Domenico D'Andrea, Lucia De Rosa, Chiara Vigliotti & Mauro Cataldi. (2016) VEGF mimic peptides: Potential applications in central nervous system therapeutics. European Journal of Molecular & Clinical Medicine 3:5, pages 233.
Crossref
. (2015) Sunitinib. Reactions Weekly 1569:1, pages 197-197.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.